{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:24:10Z","timestamp":1648967050304},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1007\/bf00053032","type":"journal-article","created":{"date-parts":[[2004,11,5]],"date-time":"2004-11-05T10:05:58Z","timestamp":1099649158000},"page":"743-749","source":"Crossref","is-referenced-by-count":1,"title":["Hemostatic variables and ischemic cardiovascular disease: Do we need a concerted effort for more profitable future clinical investigations?"],"prefix":"10.1007","volume":"10","author":[{"given":"Giovanni","family":"Di Minno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Paolo","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Margaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM198602203140806","volume":"314","author":"R Ross","year":"1986","unstructured":"Ross, R. The pathogenesis of atherosclerosis. An update. N Engl J Med 1986;314:488?500.","journal-title":"N Engl J Med"},{"key":"CR2","first-page":"249","volume":"58","author":"JM Munro","year":"1988","unstructured":"Munro, JM, Cotran, RS. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 1988;58: 249?261.","journal-title":"Lab Invest"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.80.4.1070","volume":"80","author":"D Steinberg","year":"1989","unstructured":"Steinberg, D. The cholesterol controversy is over. Why did it take so long? Circulation 1989;80:1070?1078.","journal-title":"Circulation"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.ATV.9.4.430","volume":"9","author":"SG Witt De","year":"1989","unstructured":"De, Witt, SG. Cholesterol revisited. Molecule, medicine, and media. Arteriosclerosis 1989;9:430?438.","journal-title":"Arteriosclerosis"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","volume":"326","author":"V Fuster","year":"1992","unstructured":"Fuster, V, Badimon, L, Badimon, J, Chesebro, J. The pathogenesis of coronary artery disease and the acute coronary syndromes N Engl J Med 1992;326:242?250.","journal-title":"N Engl J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.71.4.699","volume":"71","author":"E Falk","year":"1985","unstructured":"Falk, E. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and\/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699?708.","journal-title":"Circulation"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/hrt.53.4.363","volume":"53","author":"MJ Davies","year":"1985","unstructured":"Davies, MJ, Thomas, CA. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363?373.","journal-title":"Br Heart J"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0733-8651(18)30563-0","volume":"5","author":"JE Saffitz","year":"1987","unstructured":"Saffitz, JE, Schwartz, CJ. Coronary atherosclerosis and thrombosis underlying acute myocardial infarction. Cardiol Clin 1987;5:21?30.","journal-title":"Cardiol Clin"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2007-1002775","volume":"14","author":"CJ Schwartz","year":"1988","unstructured":"Schwartz, CJ, Valente, AJ, Kelley, JL, Sprague, EA, Edwards, EH. Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Hemost 1988; 14:189?195.","journal-title":"Semin Thromb Hemost"},{"key":"CR10","doi-asserted-by":"crossref","unstructured":"Bini A, Kudrik BJ. Fibrin and its derivatives in the normal and diseased vessel wall. In: Plasminogen Activation in Fibrinolysis, in Tissue Remodelling and in Development. Ann NY Acad Sci 1992;667:112?126.","DOI":"10.1111\/j.1749-6632.1992.tb51604.x"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"37G","DOI":"10.1016\/0002-9149(90)90393-F","volume":"66","author":"P Constantinides","year":"1990","unstructured":"Constantinides, P. Cause of thrombosis in human atherosclerotic arteries. Am J Cardiol 1990;66:37G-40G.","journal-title":"Am J Cardiol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(94)90049-3","volume":"73","author":"EL Smith","year":"1994","unstructured":"Smith, EL, Thompson, WD. Fibrin as a cofactor in atherogenesis. Thromb Res 1994;73:1?19.","journal-title":"Thromb Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.STR.21.8.1111","volume":"21","author":"RG Hart","year":"1990","unstructured":"Hart, RG, Kanter, MC. Hematologic disorders and ischemic stroke. A selective review. Stroke 1990:21:1111?1121.","journal-title":"Stroke"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199503093321011","volume":"332","author":"A Hamsten","year":"1995","unstructured":"Hamsten, A. Hemostatic function and coronary artery disease. N Engl J Med 1995; 332:677?678.","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","unstructured":"Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, Parts I, II and III. Br Med J 1994;308:81?106, 159?168, and 235?246.","journal-title":"Br Med J"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/bmj.288.6428.1409","volume":"288","author":"HF Heller","year":"1984","unstructured":"Heller, HF, Chinn, S, Tunstall Pedoe, HD, Rose, G. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J 1984;288:1409?1411.","journal-title":"Br Med J"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1001\/jama.1987.03390170074031","volume":"257","author":"E Ernst","year":"1987","unstructured":"Ernst, E, Hammerschmidt, DE, Bagge, U, Matrai, A, Dormandy, JA. Leukocytes and the risk of ischemic disease. JAMA 1987;257:2318?2324.","journal-title":"JAMA"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.10.1.1","volume":"10","author":"G Minno Di","year":"1990","unstructured":"Di, Minno, G, Mancini, M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis 1990;10:1?7.","journal-title":"Arteriosclerosis"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","volume":"118","author":"E Ernst","year":"1993","unstructured":"Ernst, E, Resh, KL. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review from the literature. Ann Intern Med 1993;118:956?963.","journal-title":"Ann Intern Med"},{"key":"CR20","first-page":"170","volume":"46","author":"M Margaglione","year":"1995","unstructured":"Margaglione, M, Grandone, E, Mancini, FP, Di, Minno, G. Drugs affecting plasma fibrinogen levels. Implications for new antithrombotic strategies. Progr Drug Res 1995;46: 170?181.","journal-title":"Progr Drug Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","volume":"2","author":"A Hamsten","year":"1987","unstructured":"Hamsten, A, De, Faire, U, Walldius, G, et al. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;2:3?9.","journal-title":"Lancet"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.ATV.8.1.68","volume":"8","author":"J Auwerx","year":"1988","unstructured":"Auwerx, J, Bouillon, R, Collen, D, Gebeors, J. Tissue type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988;8:68?72.","journal-title":"Arteriosclerosis"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/01.ATV.9.3.362","volume":"9","author":"I Juhan-Vague","year":"1989","unstructured":"Juhan-Vague, I Alessi, MC, Joly, P, et al. Plasma plasminogen activator inhibitor 1 in angina pectoris. Influence of plasma insulin, and acute-phase response. Arteriosclerosis 1989;9:381?387.","journal-title":"Arteriosclerosis"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jama.1994.03510370051031","volume":"271","author":"EJ Schaefer","year":"1994","unstructured":"Schaefer, EJ, Lamon-Fava, S, Jenner, JL, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994;271:999?1003.","journal-title":"JAMA"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.1995.03520400039041","volume":"273","author":"PM Ridker","year":"1995","unstructured":"Ridker, PM, Stampfer, MJ, Hennekens, CH. Plasma concentrations of lipoprotein(a) and the risk of future stroke. JAMA 1995;273:1269?1273.","journal-title":"JAMA"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI114625","volume":"85","author":"AM Scanu","year":"1990","unstructured":"Scanu, AM, Fless, GM. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest 1990;85:1709?1715.","journal-title":"J Clin Invest"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.81.1.107","volume":"81","author":"G Simone De","year":"1990","unstructured":"De, Simone, G, Devereux, RB, Chien, S, Alderman, MH, Atlas, SA, Laragh, JH. Relation of blood viscosity to demographic and physiologic variables in apparently normal adults. Circulation 1990;81:107?117.","journal-title":"Circulation"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.2.5153.673","volume":"2","author":"GDO Lowe","year":"1980","unstructured":"Lowe, GDO, Drummond, MM, Lorimer, AR, Hutton, I, Forbes, CD, Prentice, CRM, Barbenel, JC. Relation between extent of cornary artery disease and blood viscosity. Br Med J 1980;2:673?674.","journal-title":"Br Med J"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/0002-9149(91)90333-G","volume":"68","author":"G Simone De","year":"1991","unstructured":"De, Simone, G, Devereux, RB, Roman, MJ, et al. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in young adults. Am J Cardiol 1991;68:1704?1708.","journal-title":"Am J Cardiol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/01.CIR.76.5.1110","volume":"76","author":"EEW Ernst","year":"1987","unstructured":"Ernst, EEW, Matrai, A. Intermittent claudication, exercise and blood rheology. Circulation 1987;76:1110?1114.","journal-title":"Circulation"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00226411","volume":"3","author":"M Margaglione","year":"1996","unstructured":"Margaglione, M, Grandone, E, Mancini, FD, Di, Minno, G. Genetic modulation of plasma fibrinogen concentrations: Possible importance of interleukin-6. J Thromb Thrombolysis 1996;3:51?56.","journal-title":"J Thromb Thrombolysis"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","volume":"268","author":"SJ Dawson","year":"1993","unstructured":"Dawson, SJ, Wiman, B, Hamsten, A, Green, F, Humphries, S, Henney, AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-lin HepG2 cells. J Biol Chem 1993;268:10739?10745.","journal-title":"J Biol Chem"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/07853899109150515","volume":"23","author":"VV Valtonen","year":"1991","unstructured":"Valtonen, VV. Infection as a risk factor for infarction and atherosclerosis. Ann Med 1991;23:539?543.","journal-title":"Ann Med"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(88)92657-8","volume":"2","author":"JS Yudkin","year":"1988","unstructured":"Yudkin, JS, Forrest, RD, Jackson, CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988;2:530?533.","journal-title":"Lancet"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/diab.41.6.736","volume":"41","author":"MB Mattock","year":"1992","unstructured":"Mattock, MB, Morrish, NJ, Viberti, GC, Keen, H, Fitzgerald, AP, Jackson, G. Microalbuminuria as a predictor of mortality in NIDDM: A prospective study. Diabetes 1992;41: 736?741.","journal-title":"Diabetes"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ki.1992.128","volume":"41","author":"J Messent","year":"1992","unstructured":"Messent, J, Eliott, T, Jarret, RJ, Keen, H, Viberti, GC. The prognostic significance of microalbuminuria in insulindependent diabetes mellitus: A 23 years follow-up study. Kidney Int 1992;41:836?839.","journal-title":"Kidney Int"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/bmj.294.6588.1651","volume":"294","author":"K Borch-Johnsen","year":"1987","unstructured":"Borch-Johnsen, K, Kreiner, S. Proteinuria: Value as predictor of cardiovascular mortality in insulin-dependent diabetes. Br Med J 1987;294:1651?1654.","journal-title":"Br Med J"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF00274218","volume":"30","author":"T Jensen","year":"1987","unstructured":"Jensen, T, Borch-Johnsen, K, Kofoed-Enevoldsen, A, Deckert, T. Coronary heart disease in young type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. diabetologia 1987; 30:144?148.","journal-title":"diabetologia"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/BF00404141","volume":"33","author":"NJ Morrish","year":"1990","unstructured":"Morrish, NJ, Stevens, LK, Head, J, Fuller, JH, Jarrett, RJ, Keen, K. A prospective study of mortality among middleaged diabetic patients: The London cohort of the WHO Multinational Study of Vascular Disease in diabetics. I: Causes and death rates. Diabetologia 1990;33:538?541 and 542?548.","journal-title":"Diabetologia"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF00400278","volume":"34","author":"NJ Morrish","year":"1991","unstructured":"Morrish, NJ, Stevens, LK, Head, J, Fuller, JH, Keen, K, Jarrett, RJ. Incidence of macrovascular disease in diabetes mellitus: The London cohort of the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 1991;34: 584?589 and 590?594.","journal-title":"Diabetologia"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bmj.298.6672.487","volume":"298","author":"SL Jones","year":"1989","unstructured":"Jones, SL, Close, CF, Mattock, MB, Jarrett, RJ, Keen, H, Viberti, GC. Plasma lipid and coagulation factor concentration in insulin-dependent diabetics with microalbuminuria. Br Med J 1989;298:487?490.","journal-title":"Br Med J"},{"key":"CR42","unstructured":"Mattock MB, Fitzgerald A, Keen H, Viberti GC, Morrish NJ, Jackson PG. Hypercholesterolemia explains much of the predictive power of microalbuminuria for mortality in type 2 (non-insulin-dependent) diabetes. Diabetologia 1991; (Suppl 2):A11."},{"key":"CR43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-105-2-173","volume":"105","author":"PN Casale","year":"1986","unstructured":"Casale, PN, Devereux, RB, Milner, M, Zullo, M, Harshfield, GA, Pickering, TG, Laragh, JH. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986;105:173?178.","journal-title":"Ann Intern Med"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-110-2-101","volume":"110","author":"D Levy","year":"1989","unstructured":"Levy, D, Garrison, RJ, Savage, DD, Kannel, WB, Castelli, WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. Ann Intern Med 1989;110: 101?107.","journal-title":"Ann Intern Med"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy, D, Garrison, RJ, Savage, DD, Kannel, WB, Castelli, WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561?1566.","journal-title":"N Engl J Med"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","volume":"11","author":"MJ Koren","year":"1991","unstructured":"Koren, MJ, Devereux, RB, Casale, PN, Savage, DD, Laragh, JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;11:345?352.","journal-title":"Ann Intern Med"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9149(90)90807-D","volume":"65","author":"RS Cooper","year":"1990","unstructured":"Cooper, RS, Simmons, BE, Castaner, A, Santhanam, V, Ghali, J, Mar, M. Left ventricular hypertrophy is associated with worse survival independent of left ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 1990;65:441?445.","journal-title":"Am J Cardiol"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","volume":"36","author":"JS Silberberg","year":"1989","unstructured":"Silberberg, JS, Barre, PE, Prichard, SS, Sniderman, AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36:286?290.","journal-title":"Kidney Int"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0002-9149(88)90220-2","volume":"62","author":"J Blake","year":"1988","unstructured":"Blake, J, Devereux, RB, Herrold, EMcM, Borer, JF, Laragh, JH. Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension. Am J Cardiol 1988;62:246?252.","journal-title":"Am J Cardiol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/0735-1097(88)90475-5","volume":"12","author":"M Fujita","year":"1988","unstructured":"Fujita, M, Mikuniya, A, McKown, DP, Franklin, D. Regional myocardial volume alterations induced by brief repeated coronary occlusion in conscious dogs. J Am Coll Cardiol 1988;12:1048?1053.","journal-title":"J Am Coll Cardiol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0038-1653761","volume":"73","author":"DN Nguyen","year":"1995","unstructured":"Nguyen, DN, Ghaddar, H, Stinson, V, Chambless, LE, Wu, KK. ARIC hemostatic study-IV. Intraindividual variability and reliability of hemostatic factors. Thromb Haemost 1995; 73:256?260.","journal-title":"Thromb Haemost"},{"key":"CR52","first-page":"1189","volume-title":"Haemostasis and Thrombosis","author":"KA Bauer","year":"1994","unstructured":"Bauer, KA. Detection of a prethrombotic state. In: Bloom, AL, Forbes, CD, Thomas, DP, Tuddenham, EGD, eds. Haemostasis and Thrombosis. New York: Churchill-Livingstone, 1994:1189?1198."},{"key":"CR53","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0140-6736(91)92719-I","volume":"338","author":"JF Martin","year":"1991","unstructured":"Martin, JF, Bath, PMW, Burr, ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338: 1409?1411.","journal-title":"Lancet"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/1050-1738(92)90039-U","volume":"2","author":"C Patrono","year":"1992","unstructured":"Patrono, C, Davis, G, Ciabattoni, G. Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors. Trends Cardiovasc Med 1992;2:15?20.","journal-title":"Trends Cardiovasc Med"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey, CJ, Beresford, SAA, Omenn, GS, Motulsky, AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049?1057.","journal-title":"JAMA"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(95)00001-1","volume":"78","author":"DA Triplett","year":"1995","unstructured":"Triplett, DA. Antiphospholipid protein antibodies: Laboratory detection and clinical relevance. Thromb Res 1995;78: 1?31.","journal-title":"Thromb Res"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","volume":"332","author":"SG Thompson","year":"1995","unstructured":"Thompson, SG, Kienast, J, Pyke, SDM, Haverkate, F, Van De, Loo, JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635?641.","journal-title":"N Engl J Med"},{"key":"CR58","doi-asserted-by":"crossref","unstructured":"Consensus Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986;256:744?749.","DOI":"10.1001\/jama.1986.03380060070028"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/bmj.300.6741.1679","volume":"300","author":"PH Whincup","year":"1990","unstructured":"Whincup, PH, Cook, DG, Phillips, AN, Shaper, AG. ABO blood groups and ischaemic heart disease in British men. Br Med J 1990;300:1679?1682.","journal-title":"Br Med J"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.83.3.836","volume":"83","author":"JWG Yarnell","year":"1992","unstructured":"Yarnell, JWG, Baker, IA, Sweetnam, PM, Bainton, D, O'Brien, JR, Whitehead, PJ, Elwood, PC. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease. Circulation 1992;83:836?844.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00053032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00053032\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00053032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T17:50:03Z","timestamp":1624816203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00053032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["BF00053032"],"URL":"https:\/\/doi.org\/10.1007\/bf00053032","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}